Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
19.04 AUD | -6.04% | -17.65% | -23.79% |
05-28 | Transcript : Neuren Pharmaceuticals Limited - Shareholder/Analyst Call | |
05-27 | Neuren Phase 2 Trial Shows Significant Improvements in Pitt Hopkins Syndrome | CI |
End-of-day quotes
Sector Other Pharmaceuticals
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
1.73B | ||||||
748B | ||||||
598B | ||||||
356B | ||||||
325B | ||||||
283B |